Expression of Smad4, TGF-βRII, and P21 in Esophageal Squamous Cell Carcinoma Tissue

Overview

Journal Oncol Lett

Specialty Oncology

Date 2015 Jul 3

PMID 26137158

Citations 6

Authors

Hui Cheng

Cheng Chen

L U Liu

N A Zhan

Benhui Li

Affiliations

Soon will be listed here.

Abstract

Esophageal squamous cell carcinoma (SCC) possesses one of the worst prognoses out of the digestive carcinomas. Several studies have suggested that transforming growth factor β receptor type II (TGF-βRII), Smad family member 4 (Smad4) and p21 wild-type p53-activated factor 1 (p21) are associated with esophageal SCC. The aim of the present study was to evaluate the effect of Smad4, TGF-βRII and p21 in esophageal squamous cancer tissue and the pathological significance of the effect. An immunohistochemical method was used to evaluate the expression levels of Smad4, TGF-βRII and p21 in specimens of esophageal SCC lesions obtained from 80 patients. It was found that the expression of Smad4, TGF-βRII and p21 in histologically-classified grade I esophageal SCC, without invasion or lymph node metastasis, was markedly higher compared with grade III esophageal SCC that had invaded into the deep muscular or serous layer and metastasized to the lymph nodes (P<0.05). Analysis of the expression level of Smad4, TGF-βRII and p21, as well as the clinical and pathological characteristics of esophageal SCC, revealed that the three proteins may be associated with the carcinogenesis, biological behavior and prognosis of esophageal SCC, parallel to the pathological stage and cell grade.

Citing Articles

Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer.

Shan H, Tian G, Zhang Y, Qiu Z Cancer Biol Ther. 2024; 25(1):2392341.

PMID: 39164192 PMC: 11340766. DOI: 10.1080/15384047.2024.2392341.

Aldehyde Dehydrogenase Isoform 1 Predicts a Poor Prognosis of Acute Cerebral Infarction.

Yang J, Duan J, Li M, Sun H, Sun Y, Pan W Contrast Media Mol Imaging. 2022; 2022:8199917.

PMID: 35909581 PMC: 9307396. DOI: 10.1155/2022/8199917.

The role of splicing factor PRPF8 in breast cancer.

Cao D, Xue J, Huang G, An J, An W Technol Health Care. 2022; 30(S1):293-301.

PMID: 35124606 PMC: 9051661. DOI: 10.3233/THC-THC228028.

Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche.

Han P, Cao P, Hu S, Kong K, Deng Y, Zhao B Cancer Manag Res. 2020; 12:5857-5879.

PMID: 32765088 PMC: 7371556. DOI: 10.2147/CMAR.S258215.

Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.

Ma Y, He S, Gao A, Zhang Y, Zhu Q, Wang P Clin Epigenetics. 2020; 12(1):25.

PMID: 32046777 PMC: 7014638. DOI: 10.1186/s13148-020-0819-6.

References

Sarbia M, Stahl M, Hausen A, Zimmermann K, Wang L, Fink U . Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities. Clin Cancer Res. 1998; 4(11):2615-23. View

Erber R, Klein W, Andl T, Enders C, Born A, Conradt C . Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer. 1997; 74(4):383-9. DOI: 10.1002/(sici)1097-0215(19970822)74:4<383::aid-ijc4>3.0.co;2-r. View

Lam K, Law S, Tin L, Tung P, Wong J . The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Am J Gastroenterol. 1999; 94(8):2060-8. DOI: 10.1111/j.1572-0241.1999.01278.x. View

Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H . Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002; 8(6):1838-42. View

Lagna G, Hata A, Hemmati-Brivanlou A, Massague J . Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 1996; 383(6603):832-6. DOI: 10.1038/383832a0. View

Zlotta A, Noel J, Fayt I, Drowart A, van Vooren J, Huygen K . Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol. 1999; 161(3):792-8. View

Garcia Del Muro X, Condom E, Vigues F, Castellsague X, Figueras A, Munoz J . p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Cancer. 2004; 100(9):1859-67. DOI: 10.1002/cncr.20200. View

VIOLETTE F, SENELAR R . [Pulmonary vascular lesions caused by explosive decompression in the dog]. J Physiol (Paris). 1958; 50(2):556-7. View

Osawa H, Shitara Y, Shoji H, Mogi A, Kuwano H, Hagiwara K . Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma. Int J Oncol. 2000; 17(4):723-8. DOI: 10.3892/ijo.17.4.723. View

10.

Wang L, Kim S, Lee J, Choi Y, Kim Y, Park T . Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res. 2007; 13(1):102-10. DOI: 10.1158/1078-0432.CCR-06-1467. View

11.

Heldin C, Miyazono K, Ten Dijke P . TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997; 390(6659):465-71. DOI: 10.1038/37284. View

12.

Jeannon J, Soames J, Lunec J, Awwad S, Ashton V, Wilson J . Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Clin Otolaryngol Allied Sci. 2000; 25(1):23-7. DOI: 10.1046/j.1365-2273.2000.00318.x. View

13.

Bierie B, Moses H . TGF-beta and cancer. Cytokine Growth Factor Rev. 2005; 17(1-2):29-40. DOI: 10.1016/j.cytogfr.2005.09.006. View

14.

Omar E, Behlouli H, Chevalier S, Aprikian A . Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation. Prostate. 2001; 49(3):191-9. DOI: 10.1002/pros.1134. View

15.

Ohashi K, Nemoto T, Eishi Y, Matsuno A, Nakamura K, Hirokawa K . Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas. Virchows Arch. 1997; 430(5):389-95. DOI: 10.1007/s004280050048. View

16.

Noda H, Maehara Y, Irie K, Kakeji Y, YONEMURA T, Sugimachi K . Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma. Cancer. 2001; 92(7):1828-35. DOI: 10.1002/1097-0142(20011001)92:7<1828::aid-cncr1699>3.0.co;2-q. View

17.

Bachman K, Blair B, Brenner K, Bardelli A, Arena S, Zhou S . p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biol Ther. 2004; 3(2):221-5. DOI: 10.4161/cbt.3.2.666. View

18.

Nadal A, Jares P, Cazorla M, Fernandez P, Sanjuan X, Hernandez L . p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol. 1997; 183(2):156-63. DOI: 10.1002/(SICI)1096-9896(199710)183:2<156::AID-PATH908>3.0.CO;2-O. View

19.

Yang G, Zhang Z, Liao J, Seril D, Wang L, Goldstein S . Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int J Cancer. 1997; 72(5):746-51. DOI: 10.1002/(sici)1097-0215(19970904)72:5<746::aid-ijc7>3.0.co;2-s. View

20.

Rose S, Goodheart M, DeYoung B, Smith B, Buller R . p21 expression predicts outcome in p53-null ovarian carcinoma. Clin Cancer Res. 2003; 9(3):1028-32. View